BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4357311)

  • 1. Central corticotropin inhibition by arginine vasotocin in the mouse.
    Pavel S; Mătrescu L; Petrescu M
    Neuroendocrinology; 1973; 12(6):371-5. PubMed ID: 4357311
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of central gonadotropin inhibiting activity of arginine vasotocin in the female mouse.
    Pavel S; Petrescu M; Vicoleanu N
    Neuroendocrinology; 1973; 11(6):370-4. PubMed ID: 4740294
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of growth of gonadal dependent structures by arginine vasotocin and purified bovine pineal fractions in immature mice and hamsters.
    Vaughan MK; Reiter RJ; McKinney T; Vaughan GM
    Int J Fertil; 1974; 19(2):103-6. PubMed ID: 4370729
    [No Abstract]   [Full Text] [Related]  

  • 4. Opposite effects of vasotocin injected intrapituitarly and intraventricularly on corticotropin release in mice.
    Pavel S
    Experientia; 1975 Dec; 31(12):1469-70. PubMed ID: 174932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pineal indoles on corticosterone and aldosterone production by isolated rat adrenal cells.
    Ng TB
    Biochem Int; 1987 Apr; 14(4):635-41. PubMed ID: 2839179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasotocin as a pineal hormone.
    Pavel S
    J Neural Transm Suppl; 1978; (13):135-55. PubMed ID: 224141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of release of corticotropin releasing hormone in cats by extremely small amounts of vasotocin injected into the third ventricle of the brain. Evidence for the involvement of 5-hydroxytryptamine-containing neurons.
    Pavel S; Cristoveanu A; Goldstein R; Calb M
    Endocrinology; 1977 Sep; 101(3):672-8. PubMed ID: 142630
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of vasotocin and mesotocin on the suprarenal gland of the frog Rana temporaria in vivo and in vitro].
    Luk'ianenko EO; Belen'kiĭ MA; Prozorovskaia MP; Polenov AL
    Zh Evol Biokhim Fiziol; 1993; 29(1):32-7. PubMed ID: 8498111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of release of luteinizing hormone in the male rat extremely small amounts of arginine vasotocin: further evidence for the involvement of 5-hydroxytryptamine-containing neurons in the mechanism of action of arginine vasotocin.
    Pavel S; Luca N; Calb M; Goldstein R
    Endocrinology; 1979 Feb; 104(2):517-23. PubMed ID: 446373
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory and stimulatory action of vasopressin on the secretion of corticotrophin in rats : structure-activity study.
    van Dijk AM; Lodewijks HM; van Ree JM; van Wimersma Greidanus TB
    Life Sci; 1981 Sep; 29(11):1107-16. PubMed ID: 6270482
    [No Abstract]   [Full Text] [Related]  

  • 11. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
    Feuerstein G; Zerbe RL; Faden AI
    J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal O 2 consumption as an index of thyroid status: standardization of method.
    Denckla WD
    Endocrinology; 1973 Jul; 93(1):61-73. PubMed ID: 4351319
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of the preovulatory surge of luteinizing hormone and subsequent ovulation in the rat by arginine vasotocin.
    Cheesman DW; Osland RB; Forsham PH
    Endocrinology; 1977 Oct; 101(4):1194-202. PubMed ID: 332492
    [No Abstract]   [Full Text] [Related]  

  • 14. Contractile activity of vasotocin, oxytocin, and vasopressin on mammalian prostate.
    Bodanszky M; Sharaf H; Roy JB; Said SI
    Eur J Pharmacol; 1992 Jun; 216(2):311-3. PubMed ID: 1397015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar effects of arginine-vasopressin and arginine-vasotocin on permeability of toad skin.
    Elliott AB
    Experientia; 1967 Mar; 23(3):220-1. PubMed ID: 4383305
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of action of vasotocin in the mammalian brain.
    Pavel S
    Prog Brain Res; 1979; 52():445-58. PubMed ID: 317668
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland.
    Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H
    Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 8-arginine vasotocin on plasma prolactin and follicle-stimulating hormone surges in the proestrous rat.
    Cheesman DW; Osland RB; Forsham PH
    Proc Soc Exp Biol Med; 1977 Nov; 156(2):369-72. PubMed ID: 563071
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.
    Yates FE; Russell SM; Dallman MF; Hodge GA; McCann SM; Dhariwal AP
    Endocrinology; 1971 Jan; 88(1):3-15. PubMed ID: 4320769
    [No Abstract]   [Full Text] [Related]  

  • 20. Arginine-vasotocin (AVT)--a pineal hormone in mammals.
    Goldstein R
    Rom J Endocrinol; 1992; 30(1-2):21-44. PubMed ID: 1305517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.